Biohaven Pharmaceuticals

My offices (who I have great relationships with) aren't laughing? Are your offices laughing? As a matter of fact they're quite excited for our product to launch..S U B L I N G U A L hehe

 

Too late to the party. You keep that hope as long as you can ! Haha . And keep stopping in with no new nothing . Haha

 

Scary to think people like you are walking amongst us. You sound like a child. Time to grow up little buddy.

 

You will be fighting for table crumbs from a marketplace perspective, and Allergan will eat your breakfast, lunch and dinner. The level of staffing is consistent with launching a drug in the 90s; times have changed.

 

I am sure they will use the same sales force to promote the other drugs in the pipeline.

 

Company will be bought.. if they can sustain the spend on too many reps who are tripping on each other to “stop in” offices to discuss ???

 

Yet you're here shaking in your boots..move along little grasshopper.

 

Allergan rep here: you people are a joke. See you on the unemployment line!!! LOL

 

Allergan rep, you are an ass. Sure Biohaven is a cluster and will self implode, that does not make you and your sleazy company any better. You will get it soon enough.

 

sold to another company???

You mean like Allergan got sold to AbbVie....

 

Regardless of the fact that Allergan launched 1st, Biohaven has the better product. Allergan better get what they can while they can whenever wherever because once we lunch they will be the one's begging for favors.

 

Don’t kid yourself, you are all going to begging for favors.


The Institute for Clinical and Economic Review's new draft report on Eli Lilly’s Reyvow, Allergan’s ubrogepant and Biohaven’s rimegepant concludes with “moderate certainty” the drugs provide a “small or substantial” health benefit for patients who can’t take or haven't responded to triptans, a class of older migraine treatments.

But for those who can, ICER rated ubrogepant and rimegepant as “comparable or inferior” to the existing meds. And Lilly’s Reyvow is likely to perform worse than the existing options, the group said.

 

https://pioneerinstitute.org/featured/study-urges-caution-before-adopting-icer-reviews-to-determine-cost-effectiveness-of-treatments/

this group is questionable but use it as your excuse .. for whatever .. sad pathetic new company with no approval ..

 

Allergan Rep, already promoting in field. Ha , I will leave you a few bread crumbs you can have LOL LOL

enjoy your 6 month severance!!!!!JAAAAAAA HAAAAAA

 

So who is getting fired over at BHVN for spending 105 MILLION DOLLARS on a voucher to launch the same time as Allergan? #whoshitthebed #fail

 

Allergan primary care lifers and what they call specialty reps (also primary care reps) will be in the unemployment line standing right next to Biohaven reps . Abbvie will slit throats when they buy Allergan.

 

Because launching 9 months later woulda been much worse? But, hey, you know how to hashtag so you have that going for you.

 

This board seem to forget that most migraine patients are already on Ajovy, Aimovig or Evenity. It shows the inexperience of this company to think Allergan is the competition.

 

All Migraine products are our competition of course. There has been more talk around Allergan because they have the newer product with closest similarities to ours. Duhhh

 

you’ve obviously not sold migraine meds...or if you have, I hope you’re with Allergan most patients on a preventative (ajovy, aim, emg) will still have breakthrough migraines & require acute/abortive meds. The new preventatives are great, but they’re not a cure for migraine. Some patients aren’t bad enough to require a preventative & those three products aren’t indicated for use unless the patient has multiple migraines a month. If you talk to a migraine sufferer, you’ll find they’re on a cocktail of multiple meds in most cases ...triptans & allergans product is Biohaven’s competition...